Literature DB >> 11273859

Bone mineral content in girls perinatally infected with HIV.

K O O'Brien1, M Razavi, R A Henderson, B Caballero, K J Ellis.   

Abstract

BACKGROUND: Early diagnostic efforts and advances in multidrug therapy have considerably prolonged the survival time of children infected perinatally with HIV. Despite these advances, few studies have addressed calcium status and bone growth in HIV-infected children.
OBJECTIVE: Our objective was to examine the effect of HIV infection on calcium status and bone growth in children.
DESIGN: We measured calcitropic hormones, urinary calcium excretion, bone mineral content, and body composition in 19 young girls aged 9.2 +/- 2.6 y (range: 5.9-15.2 y) who were infected perinatally with HIV.
RESULTS: Serum concentrations of 1,25-dihydroxyvitamin D [1,25(OH)(2)D] and parathyroid hormone concentrations were elevated above normal ranges in 25% and 12% of these girls, respectively. Urinary calcium excretion normalized for creatinine excretion was also elevated (Ca/Cr >0.18) in 17% of these children despite suboptimal calcium intakes (679 +/- 437 mg/d). Total-body bone mineral content, measured with the use of dual-energy X-ray absorptiometry, averaged 845.1 +/- 279.0 g and was on average 2.7 z scores below age- and race-matched values reported in non-HIV-infected healthy girls. Significant positive correlations were found between an indirect marker of bone resorption in urine (N:-telopeptide) and 1,25(OH)2D (P < 0.02, r2 = 0.586, n = 9), and between serum N-telopeptide and total alkaline phosphatase (P < 0.001, r2 = 0.541, n = 17), suggesting that calcium insufficiency may be increasing bone resorption in this group.
CONCLUSIONS: Young girls with HIV infection had low bone mass and evidence of calcium insufficiency. Nutritional counseling of children with HIV infection should emphasize adequate calcium intakes because of the importance of this age period in bone mineral acquisition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273859     DOI: 10.1093/ajcn/73.4.821

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  20 in total

1.  Metabolic bone disease in human immunodeficiency virus-infected children.

Authors:  Stephen Arpadi; Mary Horlick; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 2.  Using stable isotope tracers to study bone metabolism in children.

Authors:  Kimberly O O'Brien; Steven A Abrams
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

Review 3.  Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Authors:  Roy J Kim; Richard M Rutstein
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 4.  Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges.

Authors:  Elizabeth D Lowenthal; Sabrina Bakeera-Kitaka; Tafireyi Marukutira; Jennifer Chapman; Kathryn Goldrath; Rashida A Ferrand
Journal:  Lancet Infect Dis       Date:  2014-01-07       Impact factor: 25.071

5.  Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.

Authors:  Aylin B Unsal; Aviva S Mattingly; Sara E Jones; Julia B Purdy; James C Reynolds; Jeffrey B Kopp; Rohan Hazra; Colleen M Hadigan
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

Review 6.  Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

Authors:  Grace A McComsey; Pablo Tebas; Elizabeth Shane; Michael T Yin; E Turner Overton; Jeannie S Huang; Grace M Aldrovandi; Sandra W Cardoso; Jorge L Santana; Todd T Brown
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

7.  Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life.

Authors:  Michael T Yin; Emily Lund; Jayesh Shah; Chiyuan A Zhang; Marc Foca; Natalie Neu; Kyle K Nishiyama; Bin Zhou; Xiangdong E Guo; John Nelson; David L Bell; Elizabeth Shane; Stephen M Arpadi
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

8.  Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.

Authors:  A J Rovner; V A Stallings; R Rutstein; J I Schall; M B Leonard; B S Zemel
Journal:  Osteoporos Int       Date:  2016-11-11       Impact factor: 4.507

9.  Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.

Authors:  Thanyawee Puthanakit; Rachanee Saksawad; Torsak Bunupuradah; Orasi Wittawatmongkol; Thongsuai Chuanjaroen; Sasiwimol Ubolyam; Tawatchai Chaiwatanarat; Pairunyar Nakavachara; Alan Maleesatharn; Kulkanya Chokephaibulkit
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

10.  Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents.

Authors:  Stephen M Arpadi; Donald McMahon; Elaine J Abrams; Marukh Bamji; Murli Purswani; Ellen S Engelson; Mary Horlick; Elizabeth Shane
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.